Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

But recently, CGMs designed for those without diabetes, including the Abbott Lingo and the Dexcom Stelo ... Additionally, these monitors often give false low blood sugar alerts, which can create ...

The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Non-Invasive Blood Glucose Monitoring Devices Market was valued US$ 24.3 Mn in 2025 and is expected to reach US$ 68.3 Mn by 2032 growing at a CAGR of 15.9%. BURLINGAME, CA, UNITED STATES ...

Dexcom previews new data for 15-day glucose monitor Dexcom shared the first data ... The trial also found that users’ time spent in a target blood sugar range improved by 16% with Control ...

Dexcom is a leader in the continuous glucose monitor space, which are vital tools for people managing diabetes, offering discreet, wearable sensors that allow users to track their blood sugar ...